自動注射器市場——按類型、給藥途徑、療法、最終用途、全球預測,2023-2032 年
市場調查報告書
商品編碼
1267456

自動注射器市場——按類型、給藥途徑、療法、最終用途、全球預測,2023-2032 年

Autoinjectors Market - By Type, By Route of Administration, By Therapy,, By End-use & Global Forecast, 2023 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 175 Pages | 商品交期: 2-3個工作天內

價格

全球自動注射器市場預計到 2032 年將呈指數增長,這是由於慢性病的增加導致對靶向治療的需求不斷增長。

此外,新型靶向藥物的推出和藥物開發投資有望推動自動注射器市場的增長。

此外,對自行服用藥物的日益偏愛將推動未來幾年的市場需求。 此外,減少大型生物製劑產品組合中使用的設計變更的時間、風險和成本的需求日益增長,預計將推動產品在全球範圍內的採用。

全球自動注射器行業的主要參與者繼續採取戰略舉措,例如併購、合作夥伴關係以及引入帶有一次性盒和電子驅動器的可重複使用自動注射器。 這些可重複使用的自動注射器包含預填充注射器,在最大限度地使用新藥的同時提供針頭安全性。 這種新興市場的發展正在推動更多患者使用自動注射器進行自我治療,進一步促進市場擴張。

總體而言,全球自動注射器市場在類型、給藥途徑、治療、最終用途和區域方面存在分歧。

按類型劃分,預計到 2022 年一次性用品的收入份額將超過 370 億美元,並在 2032 年之前實現顯著增長。 這種增長可歸因於一次性自動注射器提供的卓越功能,例如以患者為中心和支持完整藥物輸注的易用性。

按給藥途徑,肌肉注射器預計會顯著增長,因為它們用於過敏反應和過敏反應。 此外,由於它在緊急情況下發揮重要作用,因此有望擴大該領域。

基於治療,糖尿病細分市場預計將在 2022 年佔據超過 23% 的市場份額,並在 2032 年之前呈指數增長。 這種增長是由於糖尿病患者人數的增加和相關費用的增加。 世界衛生組織估計約有 4.22 億人患有糖尿病。

在最終用途方面,由於自動注射器提供的好處(例如管理過敏反應、糖尿病、急性發作、焦慮等),預計從 2023 年到 2032 年家庭護理環境部分將顯著增長。 此外,該產品的易用性、劑量控制和自我管理等特點有望在未來支持細分市場擴張。

按地區劃分,預計歐洲自動注射器市場在 2023 年至 2032 年期間的市場份額將超過 20%。 醫療器械行業的興起、監管框架的變化以及臨床試驗/證據的透明度是估計刺激歐洲自動注射器行業增長的主要因素。

內容

第 1 章研究方法和範圍

第 2 章執行摘要

第 3 章自動注射器行業洞察

  • 按行業細分
  • 影響行業的因素
    • 司機
      • 對靶向藥物的需求不斷增長
      • 啟動自動注射器仿製藥的全球銷售
      • 糖尿病和過敏反應的發生率增加
      • 增加了患者對藥物自我管理的偏好
    • 行業潛在的風險和挑戰
      • 存在或不存在替代治療方案
      • 自動注射器定價高
  • 增長分析
    • 按類型
    • 按給藥途徑
    • 通過治療
    • 按最終用途
  • COVID-19 影響分析
  • 監管狀況
    • 美國
    • 歐洲
  • 技術概況
  • 工業生態系統
    • 當前行業趨勢
    • 啟動場景
  • 波特分析
  • PESTEL 分析

第四章競爭格局

  • 簡介
  • 每家公司的市場份額(2021 年)
  • 主要市場參與者的競爭分析
  • 競爭對手定位矩陣
  • 戰略視角矩陣

第 5 章自動注射器市場:按類型

  • 主要類型趨勢
  • 一次性的
  • 可重複使用

第 6 章自動注射器市場:按給藥途徑

  • 主要給藥途徑的趨勢
  • 皮下
  • 肌肉注射

第 7 章自動注射器市場:按治療

  • 主要治療趨勢
  • 類風濕性關節炎
  • 多發性硬化症
  • 過敏反應
  • 糖尿病
  • 腫瘤
  • 支氣管哮喘
  • 偏頭痛
  • 激素療法
  • 其他

第 8 章自動注射器市場:按最終用途分類

  • 主要的最終用戶趨勢
  • 醫院和診所
  • 家庭護理設置
  • 其他

第 9 章自動注射器市場:按地區

  • 主要區域趨勢
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 意大利
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳大利亞
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙特阿拉伯

第十章公司簡介

  • AbbVie Inc.
  • Mylan
  • GlaxoSmithKline Plc.
  • Ypsomed
  • Amgen
  • Becton, Dickinson and company
  • Eli Lilly and Company
  • Johnson & Johnson
  • Teva pharmaceuticals
  • Antares Pharma
Product Code: 5412

Global Autoinjectors Market is slated to grow exponentially by 2032, owing to the rising demand for targeted therapies, in light of the growing prevalence of chronic diseases. In addition, introduction to novel targeted medicines and investments in drug development is slated to drive the growth of the autoinjectors market.

Besides, the rising preference for self-administration medication would propel the market demand in the ensuing years. Moreover, the increasing requirement to reduce the time and risk and expense of modifying designs that could be used across large biologic pharmaceutical portfolios are anticipated to foster the product adoption worldwide.

The key players in the global autoinjector industry are continuously incorporating strategic initiatives such as mergers and acquisitions, partnerships, and introducing reusable autoinjectors with disposable cassettes and electronic drive units. These reusable autoinjectors contain prefilled syringes and provide needle safety while maximizing the use of novel drugs. Such developments encourage more patients to use autoinjectors for self-administered medications, further augmenting market expansion.

Overall, the global autoinjectors market is bifurcated in terms of type, route of administration, therapy, end-use, and region.

Considering the type, the disposables segment held over USD 37 billion revenue share in 2022 and is slated to demonstrate massive growth through 2032. The growth can be attributed to the exceptional features offered by disposable autoinjectors, such as being patient-centric and easy operability to support the complete injection of medication.

By route of administration, the intramuscular autoinjectors segment is slated to grow considerably owing to its use for anaphylaxis and allergic reactions. In addition, these autoinjectors play a key role during an emergency, which will further support the segmental expansion.

Based on therapy, the diabetes segment held more than 23% market share in 2022 and is expected to grow exponentially through 2032. The growth can be credited to the rising cases and subsequent increase in expenses of diabetes. As per WHO estimates, approximately 422 million people suffer from diabetes.

By end-use, the homecare settings segment is depicted to grow notably during 2023-2032, owing to the benefits offered by autoinjectors, including managing anaphylaxis, diabetes, acute seizures, anxiety, and others. In addition, the product's capabilities, such as being easy usage, controlled dosage, and self-administrability, are further expected to support the segmental expansion in the future.

Regionally, the Europe global autoinjectors market is slated to exhibit over 20% market share between 2023-2032. The rising medical device industry, changes in the regulatory framework and transparency in the clinical trials/evidence are some key factors that are estimated to stimulate the Europe autoinjector industry growth.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Methodology
  • 1.2 Market scope & definitions
  • 1.3 Base estimates and calculations
    • 1.3.1 North America
    • 1.3.2 Europe
    • 1.3.3 Asia Pacific
    • 1.3.4 Latin America
    • 1.3.5 MEA
  • 1.4 Forecast calculations
  • 1.5 Data validation
  • 1.6 COVID-19 impact analysis at global level
  • 1.7 Data sources
    • 1.7.1 Secondary
      • 1.7.1.1 Paid sources
      • 1.7.1.2 Unpaid sources
    • 1.7.2 Primary

Chapter 2 Executive Summary

  • 2.1 Autoinjectors market industry 360 degree synopsis, 2018 - 2032
    • 2.1.1 Business trends
    • 2.1.2 Type trends
    • 2.1.3 Route of administration trends
    • 2.1.4 Therapy trends
    • 2.1.5 End-use trends
    • 2.1.6 Regional trends

Chapter 3 Autoinjectors Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing demand for targeted therapies
      • 3.2.1.2 Availability of generic autoinjectors globally
      • 3.2.1.3 Increasing incidence of diabetes and anaphylaxis
      • 3.2.1.4 Rising patient preference towards self-administration of medication
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Availability of alternative treatment options
      • 3.2.2.2 High pricing of the autoinjectors
  • 3.3 Growth potential analysis
    • 3.3.1 By type
    • 3.3.2 By route of administration
    • 3.3.3 By therapy
    • 3.3.4 By end-use
  • 3.4 COVID- 19 impact analysis
  • 3.5 Regulatory landscape
    • 3.5.1 U.S.
    • 3.5.2 Europe
  • 3.6 Technology landscape
  • 3.7 Industry eco-system
    • 3.7.1 Current trends in the industry
    • 3.7.2 Start-up scenario
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis

Chapter 4 Competitive landscape

  • 4.1 Introduction
  • 4.2 Company market share, 2021
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategic outlook matrix

Chapter 5 Autoinjectors Market, By Type

  • 5.1 Key type trends
  • 5.2 Disposable
    • 5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.3 Reusable
    • 5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 6 Autoinjectors Market, By Route of Administration

  • 6.1 Key route of administration trends
  • 6.2 Subcutaneous
    • 6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.3 Intramuscular
    • 6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7 Autoinjectors Market, By Therapy

  • 7.1 Key therapy trends
  • 7.2 Rheumatoid arthritis
    • 7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 7.3 Multiple sclerosis
    • 7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 7.4 Anaphylaxis
    • 7.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 7.5 Diabetes
    • 7.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 7.6 Oncology
    • 7.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 7.7 Asthma
    • 7.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 7.8 Migraine
    • 7.8.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 7.9 Hormone therapy
    • 7.9.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 7.10 Others
    • 7.10.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 8 Autoinjectors Market, By End-use

  • 8.1 Key end-use trends
  • 8.2 Hospital & clinics
    • 8.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 8.3 Homecare Settings
    • 8.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 8.4 Others
    • 8.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 9 Autoinjectors Market, By Region

  • 9.1 Key regional trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 Middle East & Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia

Chapter 10 Company Profiles

  • 10.1 AbbVie Inc.
  • 10.2 Mylan
  • 10.3 GlaxoSmithKline Plc.
  • 10.4 Ypsomed
  • 10.5 Amgen
  • 10.6 Becton, Dickinson and company
  • 10.7 Eli Lilly and Company
  • 10.8 Johnson & Johnson
  • 10.9 Teva pharmaceuticals
  • 10.10 Antares Pharma

Data Tables

  • TABLE 1. Autoinjectors market, 2018 - 2024 (USD Million)
  • TABLE 2. Autoinjectors market, 2025- 2032(USD Million)
  • TABLE 3. Autoinjectors market, by type, 2018 - 2024 (USD Million)
  • TABLE 4. Autoinjectors market, by type, 2025- 2032 (USD Million)
  • TABLE 5. Autoinjectors market, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 6. Autoinjectors market, by route of administration, 2025- 2032(USD Million)
  • TABLE 7. Autoinjectors market, by therapy, 2018 - 2024 (USD Million)
  • TABLE 8. Autoinjectors market, by therapy, 2025- 2032(USD Million)
  • TABLE 9. Autoinjectors market, by end-use, 2018 - 2024 (USD Million)
  • TABLE 10. Autoinjectors market, by end-use, 2025- 2032(USD Million)
  • TABLE 11. Autoinjectors market, by region, 2018 - 2024 (USD Million)
  • TABLE 12. Autoinjectors market, by region, 2025- 2032(USD Million)
  • TABLE 13. Industry impact forces
  • TABLE 14. Disposable market size, by region, 2018 - 2024 (USD Million)
  • TABLE 15. Disposable market, by region, 2025- 2032(USD Million)
  • TABLE 16. Reusable market size, by region, 2018 - 2024 (USD Million)
  • TABLE 17. Reusable market, by region, 2025- 2032(USD Million)
  • TABLE 18. Subcutaneous market size, by region, 2018 - 2024 (USD Million)
  • TABLE 19. Subcutaneous market, by region, 2025- 2032(USD Million)
  • TABLE 20. Intramuscular market size, by region, 2018 - 2024 (USD Million)
  • TABLE 21. Intramuscular market, by region, 2025- 2032(USD Million)
  • TABLE 22. Rheumatoid arthritis market size, by region, 2018 - 2024 (USD Million)
  • TABLE 23. Rheumatoid arthritis market, by region, 2025- 2032(USD Million)
  • TABLE 24. Multiple sclerosis market size, by region, 2018 - 2024 (USD Million)
  • TABLE 25. Multiple sclerosis market, by region, 2025- 2032(USD Million)
  • TABLE 26. Anaphylaxis market size, by region, 2018 - 2024 (USD Million)
  • TABLE 27. Anaphylaxis market, by region, 2025- 2032(USD Million)
  • TABLE 28. Diabetes market size, by region, 2018 - 2024 (USD Million)
  • TABLE 29. Diabetes market, by region, 2025- 2032(USD Million)
  • TABLE 30. Oncology market size, by region, 2018 - 2024 (USD Million)
  • TABLE 31. Oncology market, by region, 2025- 2032(USD Million)
  • TABLE 32. Asthma market size, by region, 2018 - 2024 (USD Million)
  • TABLE 33. Asthma market, by region, 2025- 2032(USD Million)
  • TABLE 34. Migraine market size, by region, 2018 - 2024 (USD Million)
  • TABLE 35. Migraine market, by region, 2025- 2032(USD Million)
  • TABLE 36. Hormone therapy market size, by region, 2018 - 2024 (USD Million)
  • TABLE 37. Hormone therapy market, by region, 2025- 2032(USD Million)
  • TABLE 38. Other cancers market size, by region, 2018 - 2024 (USD Million)
  • TABLE 39. Other cancers market, by region, 2025- 2032 (USD Million)
  • TABLE 40. Hospital & clinics market size, by region, 2018 - 2024 (USD Million)
  • TABLE 41. Hospital & clinics market, by region, 2025- 2032(USD Million)
  • TABLE 42. Homecare settings market size, by region, 2018 - 2024 (USD Million)
  • TABLE 43. Homecare settings market, by region, 2025- 2032(USD Million)
  • TABLE 44. Other cancers market size, by region, 2018 - 2024 (USD Million)
  • TABLE 45. Other cancers market, by region, 2025- 2032(USD Million)
  • TABLE 46. North America autoinjector market size, by country, 2018 - 2024 (USD Million)
  • TABLE 47. North America autoinjector market size, by country, 2025- 2032 (USD Million)
  • TABLE 48. North America autoinjector market size, by type, 2018 - 2024 (USD Million)
  • TABLE 49. North America autoinjector market size, by type, 2025- 2032 (USD Million)
  • TABLE 50. North America autoinjector market size, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 51. North America autoinjector market size, by route of administration, 2025- 2032 (USD Million)
  • TABLE 52. North America autoinjector market size, by therapy, 2018 - 2024 (USD Million)
  • TABLE 53. North America autoinjector market size, by therapy, 2025- 2032 (USD Million)
  • TABLE 54. North America autoinjector market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 55. North America autoinjector market size, by end-use, 2025- 2032 (USD Million)
  • TABLE 56. U.S. autoinjector market size, by type, 2018 - 2024 (USD Million)
  • TABLE 57. U.S. autoinjector market size, by type, 2025- 2032 (USD Million)
  • TABLE 58. U.S. autoinjector market size, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 59. U.S. autoinjector market size, by route of administration, 2025- 2032 (USD Million)
  • TABLE 60. U.S. autoinjector market size, by therapy, 2018 - 2024 (USD Million)
  • TABLE 61. U.S. autoinjector market size, by therapy, 2025- 2032 (USD Million)
  • TABLE 62. U.S. autoinjector market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 63. U.S. autoinjector market size, by end-use, 2025- 2032 (USD Million)
  • TABLE 64. Canada autoinjector market size, by type, 2018 - 2024 (USD Million)
  • TABLE 65. Canada autoinjector market size, by type, 2025- 2032 (USD Million)
  • TABLE 66. Canada autoinjector market size, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 67. Canada autoinjector market size, by route of administration, 2025- 2032 (USD Million)
  • TABLE 68. Canada autoinjector market size, by therapy, 2018 - 2024 (USD Million)
  • TABLE 69. Canada autoinjector market size, by therapy, 2025- 2032 (USD Million)
  • TABLE 70. Canada autoinjector market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 71. Canada autoinjector market size, by end-use, 2025- 2032 (USD Million)
  • TABLE 72. Europe autoinjector market size, by country, 2018 - 2024 (USD Million)
  • TABLE 73. Europe autoinjector market size, by country, 2025- 2032 (USD Million)
  • TABLE 74. Europe autoinjector market size, by type, 2018 - 2024 (USD Million)
  • TABLE 75. Europe autoinjector market size, by type, 2025- 2032 (USD Million)
  • TABLE 76. Europe autoinjector market size, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 77. Europe autoinjector market size, by route of administration, 2025- 2032 (USD Million)
  • TABLE 78. Europe autoinjector market size, by therapy, 2018 - 2024 (USD Million)
  • TABLE 79. Europe autoinjector market size, by therapy, 2025- 2032 (USD Million)
  • TABLE 80. Europe autoinjector market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 81. Europe autoinjector market size, by end-use, 2025- 2032 (USD Million)
  • TABLE 82. Germany autoinjector market size, by type, 2018 - 2024 (USD Million)
  • TABLE 83. Germany autoinjector market size, by type, 2025- 2032 (USD Million)
  • TABLE 84. Germany autoinjector market size, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 85. Germany autoinjector market size, by route of administration, 2025- 2032 (USD Million)
  • TABLE 86. Germany autoinjector market size, by therapy, 2018 - 2024 (USD Million)
  • TABLE 87. Germany autoinjector market size, by therapy, 2025- 2032 (USD Million)
  • TABLE 88. Germany autoinjector market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 89. Germany autoinjector market size, by end-use, 2025- 2032 (USD Million)
  • TABLE 90. UK autoinjector market size, by type, 2018 - 2024 (USD Million)
  • TABLE 91. UK autoinjector market size, by type, 2025- 2032 (USD Million)
  • TABLE 92. UK autoinjector market size, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 93. UK autoinjector market size, by route of administration, 2025- 2032 (USD Million)
  • TABLE 94. UK autoinjector market size, by therapy, 2018 - 2024 (USD Million)
  • TABLE 95. UK autoinjector market size, by therapy, 2025- 2032 (USD Million)
  • TABLE 96. UK autoinjector market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 97. UK autoinjector market size, by end-use, 2025- 2032 (USD Million)
  • TABLE 98. France autoinjector market size, by type, 2018 - 2024 (USD Million)
  • TABLE 99. France autoinjector market size, by type, 2025- 2032 (USD Million)
  • TABLE 100. France autoinjector market size, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 101. France autoinjector market size, by route of administration, 2025- 2032 (USD Million)
  • TABLE 102. France autoinjector market size, by therapy, 2018 - 2024 (USD Million)
  • TABLE 103. France autoinjector market size, by therapy, 2025- 2032 (USD Million)
  • TABLE 104. France autoinjector market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 105. France autoinjector market size, by end-use, 2025- 2032 (USD Million)
  • TABLE 106. Italy autoinjector market size, by type, 2018 - 2024 (USD Million)
  • TABLE 107. Italy autoinjector market size, by type, 2025- 2032 (USD Million)
  • TABLE 108. Italy autoinjector market size, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 109. Italy autoinjector market size, by route of administration, 2025- 2032 (USD Million)
  • TABLE 110. Italy autoinjector market size, by therapy, 2018 - 2024 (USD Million)
  • TABLE 111. Italy autoinjector market size, by therapy, 2025- 2032 (USD Million)
  • TABLE 112. Italy autoinjector market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 113. Italy autoinjector market size, by end-use, 2025- 2032 (USD Million)
  • TABLE 114. Spain autoinjector market size, by type, 2018 - 2024 (USD Million)
  • TABLE 115. Spain autoinjector market size, by type, 2025- 2032 (USD Million)
  • TABLE 116. Spain autoinjector market size, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 117. Spain autoinjector market size, by route of administration, 2025- 2032 (USD Million)
  • TABLE 118. Spain autoinjector market size, by therapy, 2018 - 2024 (USD Million)
  • TABLE 119. Spain autoinjector market size, by therapy, 2025- 2032 (USD Million)
  • TABLE 120. Spain autoinjector market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 121. Spain autoinjector market size, by end-use, 2025- 2032 (USD Million)
  • TABLE 122. Asia Pacific autoinjector market size, by country, 2018 - 2024 (USD Million)
  • TABLE 123. Asia Pacific autoinjector market size, by country, 2025- 2032 (USD Million)
  • TABLE 124. Asia Pacific autoinjector market size, by type, 2018 - 2024 (USD Million)
  • TABLE 125. Asia Pacific autoinjector market size, by type, 2025- 2032 (USD Million)
  • TABLE 126. Asia Pacific autoinjector market size, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 127. Asia Pacific autoinjector market size, by route of administration, 2025- 2032 (USD Million)
  • TABLE 128. Asia Pacific autoinjector market size, by therapy, 2018 - 2024 (USD Million)
  • TABLE 129. Asia Pacific autoinjector market size, by therapy, 2025- 2032 (USD Million)
  • TABLE 130. Asia Pacific autoinjector market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 131. Asia Pacific autoinjector market size, by end-use, 2025- 2032 (USD Million)
  • TABLE 132. Japan autoinjector market size, by type, 2018 - 2024 (USD Million)
  • TABLE 133. Japan autoinjector market size, by type, 2025- 2032 (USD Million)
  • TABLE 134. Japan autoinjector market size, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 135. Japan autoinjector market size, by route of administration, 2025- 2032 (USD Million)
  • TABLE 136. Japan autoinjector market size, by therapy, 2018 - 2024 (USD Million)
  • TABLE 137. Japan autoinjector market size, by therapy, 2025- 2032 (USD Million)
  • TABLE 138. Japan autoinjector market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 139. Japan autoinjector market size, by end-use, 2025- 2032 (USD Million)
  • TABLE 140. China autoinjector market size, by type, 2018 - 2024 (USD Million)
  • TABLE 141. China autoinjector market size, by type, 2025- 2032 (USD Million)
  • TABLE 142. China autoinjector market size, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 143. China autoinjector market size, by route of administration, 2025- 2032 (USD Million)
  • TABLE 144. China autoinjector market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 145. China autoinjector market size, by end-use, 2025- 2032 (USD Million)
  • TABLE 146. India autoinjector market size, by type, 2018 - 2024 (USD Million)
  • TABLE 147. India autoinjector market size, by type, 2025- 2032 (USD Million)
  • TABLE 148. India autoinjector market size, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 149. India autoinjector market size, by route of administration, 2025- 2032 (USD Million)
  • TABLE 150. India autoinjector market size, by therapy, 2018 - 2024 (USD Million)
  • TABLE 151. India autoinjector market size, by therapy, 2025- 2032 (USD Million)
  • TABLE 152. India autoinjector market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 153. India autoinjector market size, by end-use, 2025- 2032 (USD Million)
  • TABLE 154. Australia autoinjector market size, by type, 2018 - 2024 (USD Million)
  • TABLE 155. Australia autoinjector market size, by type, 2025- 2032 (USD Million)
  • TABLE 156. Australia autoinjector market size, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 157. Australia autoinjector market size, by route of administration, 2025- 2032 (USD Million)
  • TABLE 158. Australia autoinjector market size, by therapy, 2018 - 2024 (USD Million)
  • TABLE 159. Australia autoinjector market size, by therapy, 2025- 2032 (USD Million)
  • TABLE 160. Australia autoinjector market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 161. Australia autoinjector market size, by end-use, 2025- 2032 (USD Million)
  • TABLE 162. Latin America autoinjector market size, by country, 2018 - 2024 (USD Million)
  • TABLE 163. Latin America autoinjector market size, by country, 2025- 2032 (USD Million)
  • TABLE 164. Latin America autoinjector market size, by type, 2018 - 2024 (USD Million)
  • TABLE 165. Latin America autoinjector market size, by type, 2025- 2032 (USD Million)
  • TABLE 166. Latin America autoinjector market size, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 167. Latin America autoinjector market size, by route of administration, 2025- 2032 (USD Million)
  • TABLE 168. Latin America autoinjector market size, by therapy, 2018 - 2024 (USD Million)
  • TABLE 169. Latin America autoinjector market size, by therapy, 2025- 2032 (USD Million)
  • TABLE 170. Latin America autoinjector market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 171. Latin America autoinjector market size, by end-use, 2025- 2032 (USD Million)
  • TABLE 172. Brazil autoinjector market size, by type, 2018 - 2024 (USD Million)
  • TABLE 173. Brazil autoinjector market size, by type, 2025- 2032 (USD Million)
  • TABLE 174. Brazil autoinjector market size, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 175. Brazil autoinjector market size, by route of administration, 2025- 2032 (USD Million)
  • TABLE 176. Brazil autoinjector market size, by therapy, 2018 - 2024 (USD Million)
  • TABLE 177. Brazil autoinjector market size, by therapy, 2025- 2032 (USD Million)
  • TABLE 178. Brazil autoinjector market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 179. Brazil autoinjector market size, by end-use, 2025- 2032 (USD Million)
  • TABLE 180. Mexico autoinjector market size, by type, 2018 - 2024 (USD Million)
  • TABLE 181. Mexico autoinjector market size, by type, 2025- 2032 (USD Million)
  • TABLE 182. Mexico autoinjector market size, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 183. Mexico autoinjector market size, by route of administration, 2025- 2032 (USD Million)
  • TABLE 184. Mexico autoinjector market size, by therapy, 2018 - 2024 (USD Million)
  • TABLE 185. Mexico autoinjector market size, by therapy, 2025- 2032 (USD Million)
  • TABLE 186. Mexico autoinjector market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 187. Mexico autoinjector market size, by end-use, 2025- 2032 (USD Million)
  • TABLE 188. MEA autoinjector market size, by country, 2018 - 2024 (USD Million)
  • TABLE 189. MEA autoinjector market size, by country, 2025- 2032 (USD Million)
  • TABLE 190. MEA autoinjector market size, by type, 2018 - 2024 (USD Million)
  • TABLE 191. MEA autoinjector market size, by type, 2025- 2032 (USD Million)
  • TABLE 192. MEA autoinjector market size, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 193. MEA autoinjector market size, by route of administration, 2025- 2032 (USD Million)
  • TABLE 194. MEA autoinjector market size, by therapy, 2018 - 2024 (USD Million)
  • TABLE 195. MEA autoinjector market size, by therapy, 2025- 2032 (USD Million)
  • TABLE 196. MEA autoinjector market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 197. MEA autoinjector market size, by end-use, 2025- 2032 (USD Million)
  • TABLE 198. South Africa autoinjector market size, by type, 2018 - 2024 (USD Million)
  • TABLE 199. South Africa autoinjector market size, by type, 2025- 2032 (USD Million)
  • TABLE 200. South Africa autoinjector market size, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 201. South Africa autoinjector market size, by route of administration, 2025- 2032 (USD Million)
  • TABLE 202. South Africa autoinjector market size, by therapy, 2018 - 2024 (USD Million)
  • TABLE 203. South Africa autoinjector market size, by therapy, 2025- 2032 (USD Million)
  • TABLE 204. South Africa autoinjector market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 205. South Africa autoinjector market size, by end-use, 2025- 2032 (USD Million)
  • TABLE 206. Saudi Arabia autoinjector market size, by type, 2018 - 2024 (USD Million)
  • TABLE 207. Saudi Arabia autoinjector market size, by type, 2025- 2032 (USD Million)
  • TABLE 208. Saudi Arabia autoinjector market size, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 209. Saudi Arabia autoinjector market size, by route of administration, 2025- 2032 (USD Million)
  • TABLE 210. Saudi Arabia autoinjector market size, by therapy, 2018 - 2024 (USD Million)
  • TABLE 211. Saudi Arabia autoinjector market size, by therapy, 2025- 2032 (USD Million)
  • TABLE 212. Saudi Arabia autoinjector market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 213. Saudi Arabia autoinjector market size, by end-use, 2025- 2032 (USD Million)

Charts & Figures

  • FIG. 1 GMI report coverage: Critical research elements
  • FIG. 2 Industry segmentation
  • FIG. 3 Top-down approach
  • FIG. 4 Market estimation and forecast methodology
  • FIG. 5 Market forecasting methodology
  • FIG. 6 Breakdown of primary participants
  • FIG. 7 Autoinjectors industry 360 degree synopsis, 2018 - 2032
  • FIG. 8 Industry segmentation
  • FIG. 9 Global autoinjectors market, 2018 - 2032 (USD Million)
  • FIG. 10 Growth potential analysis, by type
  • FIG. 11 Growth potential analysis, by route of administration
  • FIG. 12 Growth potential analysis, by therapy
  • FIG. 13 Growth potential analysis, by end-use
  • FIG. 14 Porter's analysis
  • FIG. 15 PESTEL analysis
  • FIG. 16 Competitive dashboard, 2021
  • FIG. 17 Company matrix analysis, 2021
  • FIG. 18 Competitive analysis of major market players, 2021
  • FIG. 19 Competitive positioning matrix
  • FIG. 20 Strategic outlook matrix